Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The probability of cost-effectiveness.

Anthony O'Hagan1, John W Stevens

  • 1Centre for Bayesian Statistics in Health Economics, University of Sheffield, Sheffield, UK. a.ohagan@sheffiled.ac.uk

BMC Medical Research Methodology
|March 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eliciting judgements about dependent quantities of interest: The SHeffield ELicitation Framework extension and copula methods illustrated using an asthma case study.

Pharmaceutical statistics·2022
Same author

Correction to: Response (minimum clinically relevant change) in ASD symptoms after an intervention according to CARS-2: consensus from an expert elicitation procedure.

European child & adolescent psychiatry·2021
Same author

Response (minimum clinically relevant change) in ASD symptoms after an intervention according to CARS-2: consensus from an expert elicitation procedure.

European child & adolescent psychiatry·2021
Same author

Worldwide relative smoking prevalence among people living with and without HIV.

AIDS (London, England)·2021
Same author

Identification and Characterization of a DmoB Flavin Oxidoreductase from a Putative Two-Component DMS <i>C</i>-Monooxygenase.

ACS omega·2020
Same author

Rejoinder to "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan.

Biometrics·2020
Same journal

Sparse multi-way DMDC for longitudinal classification in high dimension low sample size data.

BMC medical research methodology·2026
Same journal

Tree-based exploratory identification of predictive biomarkers in non-randomized data.

BMC medical research methodology·2026
Same journal

Comparative evaluation of interrupted time series analytical methods for healthcare quality improvement research: a Monte Carlo simulation study.

BMC medical research methodology·2026
Same journal

Methodological advances in claims-based dementia algorithms: integrating medication and clinical data for medicare populations.

BMC medical research methodology·2026
Same journal

An interpretable XGboost algorithm for predicting 30-day mortality in acute pancreatitis using routine biomarkers.

BMC medical research methodology·2026
Same journal

Increasing power and robustness in screening trials by testing stored specimens in the control arm.

BMC medical research methodology·2026
See all related articles

This study clarifies subtle distinctions in cost-effectiveness measures for medical interventions. While an individual probability of cost-effectiveness is useful, its estimation method has logical flaws.

Area of Science:

  • Health Economics
  • Decision Analysis
  • Medical Intervention Evaluation

Background:

  • Quantifying cost-effectiveness is crucial for comparing medical interventions.
  • Existing methods for cost-effectiveness analysis (CEA) have subtle differences.
  • Clarifying these distinctions is essential for accurate decision-making.

Purpose of the Study:

  • To clarify important distinctions between various cost-effectiveness quantification proposals.
  • To examine alternative measures within the framework of patient-level incremental net benefits.
  • To analyze Willan's proposed probability of cost-effectiveness for an individual.

Main Methods:

  • Conceptual analysis of cost-effectiveness measures.
  • Framework of individual, patient-level, incremental net benefits.

Related Experiment Videos

  • Examination of Willan's probability of cost-effectiveness estimation.

    • Main Results:

    • Identified subtle but important differences in cost-effectiveness quantification methods.
    • Discussed alternative measures for evaluating medical interventions.
    • Demonstrated a logical flaw in Willan's proposed estimate of individual probability of cost-effectiveness.

    Conclusions:

    • Alternative cost-effectiveness measures, including individual probability, offer valuable insights.
    • Willan's measure is a potentially useful addition but of secondary interest to most decision-makers.
    • The estimation method for individual probability of cost-effectiveness requires revision due to logical flaws.